LASER BEAM THERAPEUTICS

laser-beam-therapeutics-logo

Laser Beam Therapeutics is a medical device company that develops non-invasive devices designed to address currently unmet medical needs. Its patented, platform technology is aimed to improve the healing of ischemic and inflamed tissues in various organs. They pioneered in the field of Low Level Laser Therapy (LLLT) for the treatment of cardiovascular indications as well as autoimmune and inflammatory diseases.

#SimilarOrganizations #People #Financial #Website #More

LASER BEAM THERAPEUTICS

Social Links:

Industry:
Health Care

Founded:
2016-07-01

Address:
Beit Nehemya, HaMerkaz, Israel

Country:
Israel

Website Url:
http://www.lbtpharma.com

Total Employee:
1+

Status:
Active

Total Funding:
313 K USD

Technology used in webpage:
SPF Euro Google Google Cloud Google Cloud Iowa Google Cloud Storage


Similar Organizations

stel-life-logo

Stel Life

Stel Life simplifies health device connectivity for patients, care teams, and device companies.

Current Employees Featured

alon-sinai_image

Alon Sinai
Alon Sinai Founder & CEO @ Laser Beam Therapeutics
Founder & CEO
2016-07-01

Founder


alon-sinai_image

Alon Sinai

Investors List

pipelbiz-com_image

PipelBiz.com

PipelBiz.com investment in Funding Round - Laser Beam Therapeutics

Official Site Inspections

http://www.lbtpharma.com

Unable to get host informations!!!

Loading ...

More informations about "Laser Beam Therapeutics"

A team of maverick scientists is trying to build a bootleg version of …

Sep 7, 2019 Glybera was a made-in-Canada medical breakthrough that became the world’s most expensive drug and then quickly disappeared from the market because no one could …See details»

LBG Pharma - Latham BioPharm Group

Our team of experts provides comprehensive end-to-end support for your pharmaceutical product development efforts—from process design and development to technology transfer, to vendor …See details»

Laser Beam Therapeutics - Crunchbase Company Profile & Funding

Laser Beam Therapeutics is a medical device company that develops non-invasive devices designed to address currently unmet medical needs. Its patented, platform technology is …See details»

About | PhRMA - Pharmaceutical Research and Manufacturers of …

The Pharmaceutical Research and Manufacturers of America, PhRMA, represents the nation’s leading biopharmaceutical research companies. We strive to conduct effective advocacy for …See details»

LTR Pharma – Clinical Stage Biopharmaceutical Company

LTR Pharma’s exciting new joint venture with Restorative Sexual Health Clinic (RSHC) to launch an online healthcare platform dedicated to men’s health has been featured in The Medical …See details»

LBT Innovations - Craft

Oct 14, 2024 LBT Innovations has 5 employees at their 1 location and $1.26 m in annual revenue in FY 2024. See insights on LBT Innovations including office locations, competitors, …See details»

LBT Innovations ASX:LBT Stock Report - Simply Wall St

Nov 18, 2024 Summary of all time highs, changes and price drops for LBT Innovations; Historical stock prices; Current Share Price: AU$0.019: 52 Week High: AU$0.038: 52 Week LowSee details»

LB Pharmaceuticals - Products, Competitors, Financials, Employees ...

Headquarters Location. 575 Madison Avenue 10th Floor. New York, New York, 10022, United States. 646-588-8175See details»

Levitee Clinics and Levitee Pharmacies Provide Insight on

Oct 28, 2021 Levitee Labs has acquired its first five addiction clinics, three specialized pharmacies and pioneering technology company that cumulatively treat tens of thousands of …See details»

Levitee Labs Signs Letter of Intent to Acquire - GlobeNewswire

Oct 12, 2021 Signed LOI to acquire a compounding pharmacy in Calgary, Alberta, Canada Valuation of approximately 3.5x TTM EBITDA of $180,000Levitee Labs to use...See details»

Lotus Bio-Technology Development Corp. (OTC: LBTD)

Vancouver BC, April 13, 2022 (GLOBE NEWSWIRE) -- Point Roberts, Washington - Lotus Bio-Technology Development Corp. (OTC: LBTD) (“LBTD”) Announces Entering Into a Binding …See details»

Latham Watkins Advises on Global Blood Therapeutics billion Sale …

Aug 8, 2022 Pfizer Inc. (NYSE: PFE) and Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) have announced the companies have entered into a definitive agreement under which …See details»

LB Announces Publication of Phase 1 Clinical Study of LB-102

Jul 19, 2022 NEW YORK--(BUSINESS WIRE)--LB Pharmaceuticals Inc (LB), a biotechnology company focused on developing and commercializing novel and improved versions of …See details»

What pharma can teach biotech about the life cycle management …

May 18, 2023 We decided to set up GPTs because, as chief medical officer and head of R&D and chief operating officer, we saw an opportunity to improve the performance and …See details»

Takeda Canada Inc. concludes Letter of Intent (LOI) with the pan ...

May 16, 2024 Takeda Canada Inc. is the Canadian organization of Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK), a global, values-based, R&D-driven …See details»

GL Pharma at a glance - GL Pharma

GL Pharma was formed out of a merger of the two pharmaceutical companies Gerot and Lannacher and has a history of more than 75 years. Welcome to GL Pharma – Shaping the …See details»

Building a Resilient Pharmaceutical Organization: Talent, Diversity ...

The pharmaceutical industry is undergoing rapid transformation, driven by technological advancements, talent management challenges, and the ongoing impact of the COVID-19 …See details»

Global Blood Therapeutics’ $5.4 Billion Acquisition by Pfizer

On August 8, 2022, Global Blood Therapeutics, Inc. (“GBT”), a biopharmaceutical company dedicated to the discovery, development and delivery of life‑changing treatments that provide …See details»

LBPs: bridging innovations and challenges in manufacturing

Mar 13, 2024 In the dynamic landscape of pharmaceutical innovation, live biotherapeutic products (LBPs) have emerged as a beacon of hope and excitement. Representing a radical …See details»

linkstock.net © 2022. All rights reserved